Bio-Rad Laboratories, Inc. (BIO) posted first-quarter 2025 adjusted earnings per share (EPS) of $2.54, which surpassed the Zacks Consensus Estimate of$1.73 by 46.8%. The bottom line increased 10.9% from the prior-year quarter’s level.The quarter’s adjustments primarily eliminate the impacts of certain non-recurring items, such as the amortization of purchased intangibles, restructuring costs and losses from the change in the fair market value of equity securities.The company’s GAAP EPS was $2.29 compared w ...